DVC1-0101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DVC1-0101, covering 2023-10-04 to 2023-10-04. Get the full timeline:
Most recent: Clinical Trial Update: Randomized Phase IIb Trial of DVC1-0101 [Phase 2]